- Martin J. Gepsman sold 300 shares of NASDAQ:CME at $305.90 each, leaving him with 24,999 shares.
- CME Group plans to launch 24/7 trading for regulated cryptocurrency futures and options, aiming to meet growing client demand.
- The company’s stock price stands at $306.33, with a market capitalization of approximately $110.13 billion.
On February 20, 2026, Martin J. Gepsman, a director at NASDAQ:CME, sold 300 shares of Common Stock Class A at $305.90 each. This transaction, reported under Form 4, leaves Gepsman with 24,999 shares. CME Group, the world’s largest derivatives marketplace, operates major U.S. exchanges like CBOT, CME, NYMEX, and COMEX, benefiting from increased trading during economic uncertainty.
CME Group’s position as a leading derivatives marketplace is strengthened by its ability to capitalize on market volatility. As geopolitical tensions and tech bubble concerns rise, CME benefits from increased trading volumes. This makes CME an attractive option for investors seeking robust stock opportunities, especially during turbulent market conditions, as highlighted by Seeking Alpha.
In response to growing client demand, CME Group plans to launch 24/7 trading for its regulated cryptocurrency futures and options on May 29, pending regulatory approval. This initiative aims to provide continuous access to cryptocurrency products, allowing clients to manage exposure and trade confidently. The digital asset market reached a record $3 trillion in notional volume in 2025, underscoring the importance of this move.
CME’s current stock price is $306.33, reflecting a 0.80% increase. The stock has fluctuated between $302.64 and $308.32 today, with a 52-week high of $309.35 and a low of $244.43. CME’s market capitalization stands at approximately $110.13 billion, with a trading volume of 1,067,557 shares. This performance highlights CME’s resilience and appeal to investors seeking stability and growth.
